111 related articles for article (PubMed ID: 15630995)
1. [Salicylanilides: still a potential antibacterially active group].
Vinsová J; Imramovský A
Ceska Slov Farm; 2004 Nov; 53(6):294-9. PubMed ID: 15630995
[TBL] [Abstract][Full Text] [Related]
2. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.
Hlasta DJ; Demers JP; Foleno BD; Fraga-Spano SA; Guan J; Hilliard JJ; Macielag MJ; Ohemeng KA; Sheppard CM; Sui Z; Webb GC; Weidner-Wells MA; Werblood H; Barrett JF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1923-8. PubMed ID: 9873460
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
7. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Mahboobi S; Eichhorn E; Popp A; Sellmer A; Elz S; Möllmann U
Eur J Med Chem; 2006 Feb; 41(2):176-91. PubMed ID: 16375991
[TBL] [Abstract][Full Text] [Related]
8. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
[TBL] [Abstract][Full Text] [Related]
10. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
11. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
15. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
Yamamoto Y; Kurazono M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
Liu J; Cao R; Wu Q; Ma C; Wang Z; Peng W; Song H
Eur J Med Chem; 2009 Apr; 44(4):1737-44. PubMed ID: 18450331
[TBL] [Abstract][Full Text] [Related]
19. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
Socha AM; LaPlante KL; Rowley DC
Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of hydroxyalkenyl salicylic acids from sarcotesta of Ginkgo biloba against vancomycin-resistant Enterococcus.
Choi JG; Jeong SI; Ku CS; Sathishkumar M; Lee JJ; Mun SP; Kim SM
Fitoterapia; 2009 Jan; 80(1):18-20. PubMed ID: 18832017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
